| Sitagliptin | IC50 | 100000.0 [1] |
| Vildagliptin | IC50 | 100000.0 [1] |
| Talabostat | IC50 | 15.0 [1], 30.0 [2], 86.0 [3] |
| Talabostat | Ki | 125.0 [1], 125000.0 [2] |
| 1-Pentanone, 2-amino-3-methyl-1-(3-thiazolidinyl)-, (2S,3S)- | IC50 | 28000.0 [1] |
| 1-Pentanone, 2-amino-3-methyl-1-(3-thiazolidinyl)-, (2S,3S)- | Ki | 8170.0 [1] |
| Linagliptin | IC50 | 100000.0 [1] |
| (2S)-1-(2-((2-((5-Cyano-2-pyridyl)amino)ethyl)amino)acetyl)pyrrolidine-2-carbonitrile | IC50 | 26520.0 [1] |
| Allo-Ile-Isoindoline | IC50 | 29000.0 [1] |
| N4-(4-Chlorobenzyl)-2,4-diaminobutanoylpiperidine | IC50 | 0.22 [1], 0.48 [2], 0.5 [3] |
| N4-(4-Chlorobenzyl)-2,4-diaminobutanoylpiperidine | Ki | 0.08 [1] |
| Chg-Pro-CN | IC50 | 39873.0 [1], 41000.0 [2], 102000.0 [3] |
| 1-Pentanone, 2-amino-3-methyl-1-(1-pyrrolidinyl)-, (2S,3S)- | IC50 | 110000.0 [1] |
| 1-Pentanone, 2-amino-3-methyl-1-(1-pyrrolidinyl)-, (2S,3S)- | Ki | 24700.0 [1] |
| 2-Amino-3-methyl-1-pyrrolidin-1-YL-butan-1-one | IC50 | 153000.0 [1], 223000.0 [2] |
| (S)-2-Amino-2-cyclohexyl-1-(pyrrolidin-1-YL)ethanone | IC50 | 19000.0 [1], 42000.0 [2], 100000.0 [3] |
| Alogliptin | IC50 | 100000.0 [1] |
| N-[4-((S)-1-Amino-2-oxo-2-thiazolidin-3-yl-ethyl)-cyclohexyl]-4-trifluoromethoxy-benzenesulfonamide | IC50 | 1100.0 [1], 1180.0 [2] |
| (S)-Pyrrolidin-1-yl(pyrrolidin-2-yl)methanone | IC50 | 500000.0 [1] |
| 2-[3-[2-[2-Cyano-(S)-pyrrolidin-1-yl]-2-oxoethylamino]-3-methyl-1-oxobutyl]-1,3-dihydroisoindole | IC50 | 20000.0 [1], 100000.0 [2] |
| 2-Oxo-2-pyrrolidin-1-ylethanamine | IC50 | 1000000.0 [1] |
| (S)-3-Amino-4-oxo-4-(pyrrolidin-1-yl)butanoic acid | IC50 | 500000.0 [1] |
| (S)-2-Amino-1-(pyrrolidin-1-yl)propan-1-one | IC50 | 179000.0 [1] |
| (2S)-1-[(2S)-2-Amino-4-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-4-oxobutanoyl]pyrrolidine-2-carbonitrile | IC50 | 100000.0 [1] |
| (2S,3S)-2-Amino-3-[4-(4-fluorophenyl)phenyl]-1-[(3S)-3-fluoropyrrolidin-1-yl]butan-1-one;2,2,2-trifluoroacetic acid | IC50 | 2700.0 [1] |
| CID 56658139 | IC50 | 50000.0 [1], 1000000.0 [2] |
| (3S)-4-Oxo-4-piperidin-1-ylbutane-1,3-diamine | IC50 | 130.0 [1], 163.0 [2] |
| N-[4-((S)-1-Amino-2-oxo-2-pyrrolidin-1-yl-ethyl)-cyclohexyl]-2,4-difluoro-benzenesulfonamide | IC50 | 8800.0 [1] |
| (S)-N-(2-(2-Cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)quinoline-4-carboxamide | IC50 | 100000.0 [1] |
| N-[2-[(2S)-2-Cyanopyrrolidin-1-yl]-2-oxoethyl]quinoline-4-carboxamide | IC50 | 100000.0 [1] |
| 5-Bromo-N-[2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl]quinoline-4-carboxamide | IC50 | 100000.0 [1] |
| (S)-1-[2-((5S,7S)-3-Hydroxy-adamantan-1-ylamino)-acetyl]-pyrrolidine-2-carbonitrile | IC50 | 210000.0 [1], 500000.0 [2] |
| Omarigliptin | IC50 | 67000.0 [1], 100000.0 [2] |
| Ala-boroPro | IC50 | 60.0 [1] |
| Ala-boroPro | Ki | 125.0 [1] |
| Lys-Pro-CN | IC50 | 577.0 [1], 1000.0 [2] |
| (S)-2,6-Diamino-1-(piperidin-1-yl)hexan-1-one | IC50 | 1600.0 [1], 2100.0 [2] |
| 3-Methyl-1-oxo-1-piperidin-1-ylpentan-2-aminium | IC50 | 59000.0 [1], 62000.0 [2] |
| Ala-Pro-CN | IC50 | 110000.0 [1] |
| Ile-Isoindoline | IC50 | 43000.0 [1] |
| [(2R)-1-[(2R)-2-Amino-3-methylbutanoyl]pyrrolidin-2-yl]boronic acid | IC50 | 21.0 [1], 38.0 [2] |
| 2,5-Diamino-1-piperidin-1-yl-pentan-1-one | IC50 | 450.0 [1] |
| 2,6-Diamino-1-pyrrolidin-1-yl-hexan-1-one | IC50 | 9900.0 [1] |
| 1-(3-Cyclohexylalanyl)pyrrolidine | IC50 | 42000.0 [1] |
| 1-{2-[2-(5-Nitro-pyridin-2-ylamino)-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile | IC50 | 12000.0 [1], 16000.0 [2] |
| (2S)-2-Amino-4-[(2-chlorophenyl)methylamino]-1-piperidin-1-ylbutan-1-one | IC50 | 0.23 [1], 5.0 [2] |
| Sitagliptin Hydrochloride | IC50 | 100000.0 [1] |
| 3-[[2-[(2S)-2-Cyanopyrrolidin-1-yl]-2-oxoethyl]amino]-N-(2-phenylethyl)propanamide | IC50 | 20000.0 [1], 20720.0 [2] |
| (2S,3S)-3-Amino-4-[(3S)-3-fluoropyrrolidin-1-yl]-N,N-dimethyl-4-oxo-2-[4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)phenyl]butanamide;2,2,2-trifluoroacetic acid | IC50 | 100000.0 [1] |
| 3-[[2-[(2S)-2-Cyanopyrrolidin-1-yl]-2-oxoethyl]amino]-N-(3,4-dimethoxyphenyl)-3-methylbutanamide | IC50 | 20000.0 [1] |
| 3-[2-(2-Cyanopyrrolidin-1-yl)-2-oxo-ethylamino]-3-methyl-N-(1-methyl-1-phenylethyl)butyramide | IC50 | 20000.0 [1], 100000.0 [2] |
| N-Benzyl-3-[[2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl]amino]propanamide | IC50 | 17400.0 [1] |
| 3-[2-(2-Cyano-(S)-pyrrolidin-1-yl)-2-oxoethylamino]-N-phenylpropionamide | IC50 | 5717.6 [1], 57176.0 [2] |
| 3-[2-(2-Cyano-(S)-pyrrolidin-1-yl)-2-oxoethylamino]-N-(1-methyl-1-phenylethyl)propionamide | IC50 | 20000.0 [1], 100000.0 [2] |
| N-[2-[(2S)-2-Cyanopyrrolidin-1-yl]-2-oxoethyl]naphthalene-1-carboxamide | IC50 | 100000.0 [1] |
| 2-Amino-3-hydroxy-1-pyrrolidin-1-yl-propan-1-one | IC50 | 65000.0 [1] |
| 4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-1,4-diazepan-2-one | IC50 | 100000.0 [1] |
| (2R,3S,5R)-2-(2,5-Difluorophenyl)-5-(4,6-dihydro-1H-pyrrolo[3,4-c]pyrazol-5-yl)oxan-3-amine | IC50 | 34000.0 [1], 42000.0 [2] |
| 2-Amino-3-phenyl-1-(pyrrolidin-1-yl)propan-1-one | IC50 | 79000.0 [1] |
| 2-Amino-3-(4-hydroxy-phenyl)-1-pyrrolidin-1-yl-propan-1-one | IC50 | 150000.0 [1] |
| (S)-2-Amino-1-thiazolidin-3-yl-propane-1-thione | Ki | 277.0 [1] |
| (S)-2-Amino-1-pyrrolidin-1-yl-propane-1-thione | Ki | 1430.0 [1] |
| 2-Amino-3-(1H-imidazol-4-yl)-1-piperidin-1-yl-propan-1-one | IC50 | 328.0 [1], 330.0 [2] |
| N-[4-((S)-1-Amino-2-oxo-2-pyrrolidin-1-yl-ethyl)-cyclohexyl]-4-trifluoromethoxy-benzenesulfonamide | IC50 | 6400.0 [1] |
| [4-((S)-1-Amino-2-oxo-2-pyrrolidin-1-yl-ethyl)-cyclohexyl]-carbamic acid benzyl ester | IC50 | 4100.0 [1] |
| N-[4-((S)-1-Amino-2-oxo-2-pyrrolidin-1-yl-ethyl)-cyclohexyl]-3,4-difluoro-benzamide | IC50 | 5000.0 [1] |
| N-[4-((S)-1-Amino-2-oxo-2-thiazolidin-3-yl-ethyl)-cyclohexyl]-3,4-difluoro-benzamide | IC50 | 690.0 [1] |
| N-[4-[(1S)-1-Amino-2-oxo-2-(1,3-thiazolidin-3-yl)ethyl]cyclohexyl]-4-(trifluoromethoxy)benzamide | IC50 | 360.0 [1], 690.0 [2] |
| [4-((S)-1-Amino-2-oxo-2-thiazolidin-3-yl-ethyl)-cyclohexyl]-carbamic acid benzyl ester | IC50 | 900.0 [1] |
| (2S,4S)-1-[(2S,3R)-2-Amino-3-methylpentanoyl]-4-azidopyrrolidine-2-carbonitrile | IC50 | 24000.0 [1] |
| (S)-2,6-Diamino-1-(isoindolin-2-yl)hexan-1-one | IC50 | 1780.0 [1] |
| (S)-Benzyl 5-amino-6-(isoindolin-2-yl)-6-oxohexylcarbamate | IC50 | 2500.0 [1] |
| (2S)-1-[(2S,4S)-4-[2-(1,3-Dihydroisoindol-2-yl)-2-oxoethyl]-5-oxopyrrolidine-2-carbonyl]-4,4-difluoropyrrolidine-2-carbonitrile | IC50 | 100000.0 [1] |
| (2S,3S)-3-Amino-2-[4-(4-fluorophenyl)phenyl]-4-[(3S)-3-fluoropyrrolidin-1-yl]-N,N-dimethyl-4-oxobutanamide;2,2,2-trifluoroacetic acid | IC50 | 45000.0 [1] |
| (2S,3S)-2-Amino-3-[3-(2,4-dichlorophenyl)-1,2,4-oxadiazol-5-yl]-1-pyrrolidin-1-ylbutan-1-one;2,2,2-trifluoroacetic acid | IC50 | 1400.0 [1] |
| (2S,3S)-2-Amino-3-[3-(2-chloro-4-methylsulfonylphenyl)-1,2,4-oxadiazol-5-yl]-1-[(3S)-3-fluoropyrrolidin-1-yl]butan-1-one;2,2,2-trifluoroacetic acid | IC50 | 3500.0 [1] |
| (2S,3S)-2-Amino-3-[3-(2-chloro-4-methylsulfonylphenyl)-1,2,4-oxadiazol-5-yl]-4-cyclopropyl-1-[(3S)-3-fluoropyrrolidin-1-yl]butan-1-one;2,2,2-trifluoroacetic acid | IC50 | 1700.0 [1], 17000.0 [2] |
| (2S,3S)-2-Amino-3-[3-(2-chloro-4-methylsulfonylphenyl)-1,2,4-oxadiazol-5-yl]-1-[(3S)-3-fluoropyrrolidin-1-yl]-5-hydroxypentan-1-one;2,2,2-trifluoroacetic acid | IC50 | 44800.0 [1], 45000.0 [2] |
| (2S)-3-[3-(2-Chloro-4-methylsulfonylphenyl)-1,2,4-oxadiazol-5-yl]-1-cyclopentylidene-1-fluorobutan-2-amine;2,2,2-trifluoroacetic acid | IC50 | 330.0 [1] |
| 3-Amino-4-oxo-4-pyrrolidin-1-yl-butyramide | IC50 | 152000.0 [1] |
| 2-Amino-3-(1H-imidazol-4-yl)-1-pyrrolidin-1-yl-propan-1-one | IC50 | 1160.0 [1], 1200.0 [2] |
| N-[4-[(1R)-1-Amino-2-(2,5-difluorophenyl)ethyl]cyclohexyl]-N-methylacetamide | IC50 | 83000.0 [1], 100000.0 [2] |
| (1R)-2-(2,5-Difluorophenyl)-1-[4-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]cyclohexyl]ethanamine | IC50 | 18000.0 [1], 100000.0 [2] |
| 1-[4-[(1R)-1-Amino-2-(2,5-difluorophenyl)ethyl]cyclohexyl]piperidine-3-carboxamide | IC50 | 54000.0 [1], 62000.0 [2] |
| (1R)-2-(2,5-Difluorophenyl)-1-[4-(3,3-difluoropyrrolidin-1-yl)cyclohexyl]ethanamine | IC50 | 16000.0 [1], 31000.0 [2] |
| cis-(R)-2-(2,5-Difluorophenyl)-1-(4-(piperidin-1-yl)cyclohexyl)ethanamine | IC50 | 17000.0 [1], 77000.0 [2] |
| N-[2-[(2S)-2-Cyano-4,4-difluoropyrrolidin-1-yl]-2-oxoethyl]naphthalene-1-carboxamide | IC50 | 100000.0 [1] |
| N-[2-[(2S)-2-Cyanopyrrolidin-1-yl]-2-oxoethyl]-3-hydroxy-2-methylquinoline-4-carboxamide | IC50 | 100000.0 [1] |
| 5-Chloro-N-[2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl]quinoline-4-carboxamide | IC50 | 100000.0 [1] |
| N-[2-[(2S)-2-Cyanopyrrolidin-1-yl]-2-oxoethyl]quinoline-5-carboxamide | IC50 | 100000.0 [1] |
| N-[2-[(2S)-2-Cyanopyrrolidin-1-yl]-2-oxoethyl]-2-methylquinoline-4-carboxamide | IC50 | 100000.0 [1] |
| N-[2-[(2S)-2-Cyanopyrrolidin-1-yl]-2-oxoethyl]pyridine-4-carboxamide | IC50 | 100000.0 [1] |
| N-[2-[(2S)-2-Cyanopyrrolidin-1-yl]-2-oxoethyl]quinoline-8-carboxamide | IC50 | 100000.0 [1] |
| N-[2-[(2S)-2-Cyanopyrrolidin-1-yl]-2-oxoethyl]-6-fluoroquinoline-4-carboxamide | IC50 | 100000.0 [1] |
| 6-Chloro-N-[2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl]quinoline-4-carboxamide | IC50 | 100000.0 [1] |
| N-[2-[(2S)-2-Cyanopyrrolidin-1-yl]-2-oxoethyl]-6-(trifluoromethoxy)quinoline-4-carboxamide | IC50 | 100000.0 [1] |
| 8-Chloro-N-[2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl]quinoline-4-carboxamide | IC50 | 100000.0 [1] |
| 8-Bromo-N-[2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl]quinoline-4-carboxamide | IC50 | 100000.0 [1] |
| N-[2-[(2S)-2-Cyanopyrrolidin-1-yl]-2-oxoethyl]-6-methoxyquinoline-4-carboxamide | IC50 | 100000.0 [1] |
| 7-Bromo-N-[2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl]quinoline-4-carboxamide | IC50 | 100000.0 [1] |